13F-HR filed by GREAT POINT PARTNERS LLC
GREAT POINT PARTNERS LLC filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 42 holding rows worth $510,185,143.
- Accession
- 0001172661-23-001300
- Filer
- CIK 1281446
- Filed
- 2023-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 42 entries on the cover page, a total value of $510,185,143 stated on the cover page (in dollars after the unit check, H1), rows summing to $510,185,143 with VALUE read as dollars as filed, 13F file number 028-11743. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerJAY JEFFREY R028-12517
- included managerYehudai Ortav028-20398
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| VAXCYTE INC COM | 92243G108 | Stock | 800,000 | $38,360,000 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 850,000 | $33,515,500 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 1,436,569 | $28,444,066 | dollars as filed | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 3,637,718 | $26,737,227 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 1,322,870 | $25,571,077 | dollars as filed | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 160,000 | $25,489,600 | dollars as filed | |
| SEAGEN INC | 81181C104 | COM | 160,500 | $20,625,855 | dollars as filed | |
| POINT BIOPHARMA GLOBAL INC | 730541109 | COM | 2,541,779 | $18,529,569 | dollars as filed | |
| NOVOCURE LTD | G6674U108 | ORD SHS | 241,000 | $17,677,350 | dollars as filed | put |
| IVERIC BIO INC | 46583P102 | COM | 825,000 | $17,663,250 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 1,019,282 | $16,053,692 | dollars as filed | |
| HERON THERAPEUTICS INC | 427746102 | COM | 6,360,161 | $15,900,403 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 342,300 | $15,858,759 | dollars as filed | |
| OPTINOSE INC | 68404V100 | COM | 7,894,736 | $14,605,262 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 400,695 | $13,138,789 | dollars as filed | |
| CINCOR PHARMA INC | 17240Y109 | COM | 1,019,153 | $12,525,390 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 1,295,034 | $12,173,320 | dollars as filed | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 544,451 | $11,716,586 | dollars as filed | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 302,135 | $11,532,493 | dollars as filed | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 378,522 | $11,090,695 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 475,000 | $9,989,250 | dollars as filed | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 1,550,000 | $9,718,500 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 73,000 | $9,459,340 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 451,000 | $8,826,070 | dollars as filed | call |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 1,055,801 | $7,137,215 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 190,000 | $7,020,500 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 642,566 | $6,746,943 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 1,538,461 | $6,630,767 | dollars as filed | |
| INTERCEPT PHARMACEUTICALS IN | 45845P108 | COM | 528,850 | $6,541,875 | dollars as filed | |
| ACUMEN PHARMACEUTICALS INC | 00509G209 | CMN | 1,116,581 | $6,029,537 | dollars as filed | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 133,000 | $6,026,230 | dollars as filed | |
| VERVE THERAPEUTICS INC | 92539P101 | COM | 300,000 | $5,805,000 | dollars as filed | |
| ALBIREO PHARMA INC | 01345P106 | COMMON STOCK | 267,283 | $5,775,986 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 1,273,635 | $5,260,113 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 560,000 | $4,967,200 | dollars as filed | |
| PRECISION BIOSCIENCES INC | 74019P108 | COM | 3,801,305 | $4,523,553 | dollars as filed | |
| GRACELL BIOTECHNOLOGIES INC | 38406L103 | ADR | 1,962,399 | $4,513,518 | dollars as filed | |
| GENERATION BIO CO | 37148K100 | COM | 1,022,537 | $4,018,570 | dollars as filed | |
| EVOLUS INC | 30052C107 | COM | 190,329 | $1,429,371 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 46,185 | $1,206,814 | dollars as filed | |
| IMMUNIC INC | 4525EP101 | COM | 632,184 | $885,058 | dollars as filed | |
| ANAPTYSBIO INC | 032724106 | COM | 15,000 | $464,850 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-23-001300 | this filing | 2023-02-14 | acceptance time not in the bulk data set |